Wed, May 11, 2022
Tue, May 10, 2022
Mon, May 9, 2022
Fri, May 6, 2022

Thomas Shrader Initiated (ATHA) at Strong Buy and Held Target at $33 on, May 10th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-33-on-may-10th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Thomas Shrader of BTIG, Initiated "Athira Pharma, Inc." (ATHA) at Strong Buy and Held Target at $33 on, May 10th, 2022.

Thomas has made no other calls on ATHA in the last 4 months.



There is 1 other peer that has a rating on ATHA. Out of the 1 peers that are also analyzing ATHA, 0 agree with Thomas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Thomas


  • Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $33 on, Thursday, April 21st, 2022